More FDA Articles

  • Ben & Jerry's socialist, anti-GMO cofounder inadvertently makes the case for federalism

    Jerry Greenfield, the eponymous second half of Ben & Jerry's ice cream company, was in Washington to quash a bill that would give the FDA sole authority to mandate genetically modified organism labeling.

  • FDA grapples with oversight of fecal transplants

    WASHINGTON (AP) — Imagine a low-cost treatment for a life-threatening infection that could cure up to 90 percent of patients with minimal side effects, often in a few days. It may sound like a miracle drug, but this cutting-edge treatment is profoundly simple — though somewhat icky: take...

  • FDA warns of allergic reactions with acne products

    WASHINGTON (AP) — Federal health officials are warning consumers who use popular anti-acne treatments about rare but potentially deadly allergic reactions that can cause swelling of the face and difficulty breathing. The Food and Drug Administration said Wednesday the problems have been...

  • FDA outlines policy for overseeing nanotechnology

    WASHINGTON (AP) — Federal regulators want to hear from companies using tiny, engineered micro-particles in their products, part of an effort to stay abreast of the growing field of nanotechnology. The Food and Drug Administration issued final recommendations Tuesday for companies using...

  • Supreme Court weighs in on this juice spat

    A juicy legal battle between the makers of two rival fruit drinks can continue, as the Supreme Court on Thursday said POM Wonderful may proceed with a false advertising lawsuit against Coca-Cola. The case involves conflicting federal laws — consumer health vs. copyright — and has broad...

  • Federal cheese regs wouldn't have hurt Kraft, but they would have hurt rich people

    The Food and Drug Administration tried a sneak attack on the artisan cheese industry earlier this week, pushing a new rule, pretending it wasn't a new rule, that would outlaw the aging of cheese on wooden board. The FDA has backed down from this new-not-new rule-not-rule.

  • Who should have say on a patient taking experimental drugs?

    Darcy Olsen, president of the Arizona-based Goldwater Institute, and Richard Garr, president of Neuralstem, a biotech company, wrote "Right to Try experimental drugs" in USA Today. They pointed out that "this year, more than 5,000 Americans will lose their battle with ALS, commonly known as Lou...



From the Weekly Standard